MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 109 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,152,922 | +216.8% | 99,776 | +159.4% | 0.00% | – |
| Q2 2023 | $995,090 | +191.8% | 38,465 | +170.8% | 0.00% | – |
| Q1 2023 | $341,000 | +22158.5% | 14,203 | -81.9% | 0.00% | – |
| Q4 2022 | $1,532 | -99.5% | 78,571 | +454.0% | 0.00% | – |
| Q3 2022 | $299,000 | +51.8% | 14,183 | +39.9% | 0.00% | – |
| Q2 2022 | $197,000 | +68.4% | 10,135 | +90.5% | 0.00% | – |
| Q1 2022 | $117,000 | -67.5% | 5,319 | -76.4% | 0.00% | – |
| Q4 2021 | $360,000 | -9.8% | 22,569 | +12.9% | 0.00% | – |
| Q3 2021 | $399,000 | -42.3% | 19,996 | -50.0% | 0.00% | – |
| Q2 2021 | $691,000 | +116.6% | 39,997 | +148.4% | 0.00% | – |
| Q1 2021 | $319,000 | +678.0% | 16,105 | +590.9% | 0.00% | – |
| Q4 2020 | $41,000 | -71.7% | 2,331 | -68.8% | 0.00% | – |
| Q3 2020 | $145,000 | +61.1% | 7,480 | +61.8% | 0.00% | – |
| Q2 2020 | $90,000 | -22.4% | 4,624 | -44.0% | 0.00% | – |
| Q1 2020 | $116,000 | +10.5% | 8,264 | +93.2% | 0.00% | – |
| Q4 2019 | $105,000 | +1066.7% | 4,277 | +362.4% | 0.00% | – |
| Q3 2019 | $9,000 | – | 925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |